(Q34632529)

3 August 2017

title

Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome (English)

1 reference

3 August 2017

1 reference

Angeles Alvarez Secord

9

object named as

Angeles Alvarez Secord

1 reference

3 August 2017

Susan K Murphy

13

1 reference

ORCID Public Data File 2021

Andrew Berchuck

1

object named as

Andrew Berchuck

1 reference

3 August 2017

Edwin S Iversen

2

1 reference

3 August 2017

Jingqin Luo

3

1 reference

3 August 2017

Jennifer P Clarke

4

1 reference

3 August 2017

Hisani Horne

5

1 reference

3 August 2017

Douglas A Levine

6

1 reference

3 August 2017

Jeff Boyd

7

1 reference

3 August 2017

Miguel A Alonso

8

1 reference

3 August 2017

Marcus Q Bernardini

10

1 reference

3 August 2017

Jason C Barnett

11

1 reference

3 August 2017

Todd Boren

12

1 reference

3 August 2017

Holly K Dressman

14

1 reference

3 August 2017

Jeffrey R Marks

15

1 reference

3 August 2017

Johnathan M Lancaster

16

1 reference

3 August 2017

language of work or name

English

0 references

publication date

24 March 2009

1 reference

3 August 2017

published in

Clinical Cancer Research

1 reference

3 August 2017

volume

15

1 reference

3 August 2017

issue

7

1 reference

3 August 2017

page(s)

2448-2455

1 reference

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Utilization of genomic signatures to direct use of primary chemotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Adjusting batch effects in microarray expression data using empirical Bayes methods

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Adjustment of systematic microarray data biases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Expression of the MAL gene in the thyroid: the MAL proteolipid, a component of glycolipid-enriched membranes, is apically distributed in thyroid follicles

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Unique gene expression profile based on pathologic response in epithelial ovarian cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Mutation and expression of the TP53 gene in early stage epithelial ovarian carcinoma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Genetic analysis of early- versus late-stage ovarian tumors.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Combination chemotherapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Expression of theMALGene in the Thyroid: the MAL Proteolipid, a Component of Glycolipid-Enriched Membranes, Is Apically Distributed in Thyroid Follicles1

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3050629

Three cycles versus six cycles of adjuvant paclitaxel (Taxol)/carboplatin in early stage ovarian cancer

9 December 2018

1 reference

12 December 2020

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas

1 reference

12 December 2020

Prognostic Significance of p53 Mutation and p53 Overexpression in Advanced Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

1 reference

12 December 2020

A cross-study comparison of gene expression studies for the molecular classification of lung cancer

1 reference

12 December 2020

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

1 reference

12 December 2020

Ki67 antigen immunostaining (MIB 1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance

1 reference

12 December 2020

Gene expression signature with independent prognostic significance in epithelial ovarian cancer

1 reference

12 December 2020

Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

1 reference

12 December 2020

10.1158/1078-0432.CCR-08-2430

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference